Resources
Filter by Topic
- Resource Hubs
Finding Rare Disease Patients with Real-World Data and Analytics
- Articles
by Ragib Ahsan, Erik Maul, Eric Girouard, April Duddy, and Srini Raghavan
- Blogs
Accessing real-world data across international borders has long been a headache for life sciences companies. Data residency laws, privacy concerns, and siloed systems have historically...
- Press Releases
Exploratory data tool and Gen AI-powered assistant help life sciences teams unlock deeper RWD insights
- Press Releases
Boston, MA - May 8, 2025 - Panalgo, a Norstella company dedicated to revolutionizing healthcare data analytics, announced today that Instant Health Data (IHD) Cloud,...
- Blogs
Accessing and leveraging real-world data (RWD) is a persistent challenge for life sciences companies. Data silos, inefficiencies, and complex workflows often hinder organizations from fully...
Faster Evidence, Fewer Bottlenecks: How IHD Is Redefining What’s Possible in Evidence Generation
As the demands on real-world data teams continue to grow, with more data sources, more stakeholders, and more pressure to deliver trusted evidence faster, the tools supporting that work need to evolve just as quickly.
Accelerating HEOR and Real-World Evidence: How IHD Helps Researchers Turn Evidence Into Impact
Health economics and outcomes research (HEOR), epidemiology, and real-world evidence (RWE) teams are under growing pressure to deliver meaningful insights faster than ever before. As healthcare stakeholders demand stronger evidence of clinical, economic, and humanistic value across the product life cycle, researchers need more than data—they need the right combination of technology, expertise, and fit-for-purpose evidence sources to turn research into impact.
How Pharma Leaders Are Rethinking Evidence Generation in the AI Era
Learn what organizations must do to balance speed, transparency, governance, and innovation in an increasingly data-driven and AI-reliant environment.
Where Treatment Slows in Metastatic NSCLC: A Real-World Data Analysis of Care Delays and Access Barriers
As regulators around the world grow more comfortable with real-world data (RWD) and AI-enabled evidence generation, pharma companies are rethinking how, and when, they build evidence.
Pharma’s New Regulatory Reality: Building Evidence for Launch and Beyond
As regulators around the world grow more comfortable with real-world data (RWD) and AI-enabled evidence generation, pharma companies are rethinking how, and when, they build evidence.
Smarter Data, Better Outcomes: How Real-World Data Is Transforming Evidence Generation Across the Product Lifecycle
As real-world data (RWD) becomes more central to healthcare decision making, evidence generation is playing an increasingly important role, from early identification to treatment optimization
IHD Analytics
Put reliable, rapid analytics in the hands of more people across your organization